Latest news

Stay up to date

Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.

Fierce Biotech | December 16, 2022

EXCERPT:  Originally launched in 2021 as a joint venture between nference and Mayo Clinic, Anumana will now work with Pfizer on a multiyear research project.


Healthcare Changemakers Podcast | November 30, 2022


Mayo Clinic News Network | November 29, 2022

Additional Sources: YouTube, Apple Podcasts, Spotify


PR Newswire | November 11, 2022


Post Bulletin | October 20, 2022

EXCERPT:  “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.


BioSpace | September 20, 2022

EXCERPT:  MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19. 


Twin Cities Business | September 1, 2022

EXCERPT: Mayo Clinic Ventures chair Andrew Danielsen estimated that the accelerator will give birth to about one to three new companies a year.


1 5 6 7 8 9 10